SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (224)7/3/2011 4:19:42 PM
From: BulbaMan  Read Replies (1) | Respond to of 400
 
Bernard,
We’ve never been too strict in deciding whether a company qualifies as a “biotech” for entry in the Contest. As far as SNMX, here’s an article that does use “biotech” in association with the company.
minyanville.com
Happy Independence day!
Bulba



To: Jibacoa who wrote (224)7/3/2011 4:53:35 PM
From: hmpa2 Recommendations  Respond to of 400
 
SNMX develops molecules affecting human receptors (in their case, taste) based on fairly elaborate cell biology research and HTS. I don't see this as any different from the small-molecule drug developers that we routinely classify as biotech.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News